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Mice inoculated with replication-competent stocks of the murine acquired immunodeficiency syndrome (MAIDS) virus 
are severely immunocompromised and proned to the development of T- and B-cell lymphomas. We have studied the 
development of T-cell lymphomas in C57BL/6 and RF/J mice inoculated with helper-free stocks of the MAIDS defective 
virus. We observed the expansion of T cell clones (detected by TCR gene rearrangements and by transplantation) only 
rarely in diseased C57BL/6 mice and slightly more frequently in RF/J mice. We succeeded in establishing four transplantable 
T cell tumors and malignant cell lines. The three cell lines from RF/J mice were immature T-cells (Thy-1 +, CD3-, CD4 +, 
CD8 +, Mac-1 +), while the line from the C57BL/6 mouse had the phenotype of mature T-cells (Thy-l+, CD3 +, CD4 +, CDS-). 
All lines were virus-producers despite the fact that helper-free stocks of the virus were inoculated, These helper MuLVs 
most likely originated from endogenous MuLV sequences. Also, the defective viral genome was clearly detectable in one 
cell line and was rearranged in two other lines. These established cell lines may be useful to determine whether they share 
some of the characteristics of the anergic T-cells in vivo and to study the role of the MAIDS defective virus in T cell 
transformation. © 1995 Academic Press, Inc. 
INTRODUCTION 
The murine acquired immunodeficiency syndrome 
(MAIDS), induced by a defective retrovirus (Aziz et al., 
1989; Chattopadhyay et a/., 1989), is characterized by 
severe dysfunctions of the T and B lymphoid cell popula- 
tions (for review see (Mosier, 1986; Jolicoeur, 1991; 
Morse et al., 1992). In mice inoculated with replication- 
competent viral stocks, several cell populations have 
been reported to be infected, including T (Kubo eta/ . ,  
1992; Tang eta/., 1992) and B (Klinken eta/., 1988; Chatto- 
padhyay et al., 1991 ; Hitoshi eta/., 1993) lymphocytes and 
macrophages (Cheung et aL, 1991; Bilello et aL, 1992). 
Infection of T-cells by the MAIDS defective virus could 
play a role in the pathogenesis of the disease. Previous 
reports have indicated that infection of T-cells of mice 
inoculated with the replication-competent MAIDS LP- 
BM5 virus occurs at a relatively high frequency. Three 
studies (Fredrickson et a/., 1993; Kubo et al., 1992; Tang 
eta / . ,  1992) reported that T-cell tumors, derived from 
MAIDS-diseased mice and harboring the MAIDS defec- 
tive virus, could be transplanted efficiently in nude or 
SCID mice, respectively. In addition, an expansion of T- 
cells could also be detected as a clonal rearrangement 
of the T-cell receptor (TcR /g) gene in 35% of diseased 
MAIDS mice inoculated with the LP-BM5 virus (Klinken et 
a/., 1988). In view of the reported transplantation studies 
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(Fredrickson eta/ . ,  1993; Kubo et al., 1992; Tang et al., 
1992), some of these T-cell clones are likely to be malig- 
nant and to harbor a MAIDS defective viral genome. 
However, the interpretation of these results is compli- 
cated by the fact that the MAIDS LP-BM5 virus stocks are 
rather crude and contain several strains of nondefective 
replication-competent helper murine leukemia viruses 
(MuLVs) along with the defective virus (Astier et al., 1982; 
Guillemain eta/. ,  1980; Haas and Reshef, 1980; Legrand 
et al., 1982; Mamoun et aL, 1978; Chattopadhyay et al., 
1989; Hartley et al., 1989; Chattopadhyay et al., 1991). 
These replication-competent MuLVs, alone or in pseu- 
dotypes with the defective virus, may infect T-cells and 
play a role in their transformation. 
To overcome this problem and to study exclusively 
the cell population whose infection is required for the 
development of the specific immune defects seen in 
MAIDS, we have derived nonreplicating helper-free 
stocks of the MAIDS defective virus (Huang eta/. ,  1989). 
Interestingly, these stocks induced typical MAIDS (Hu- 
ang eta/. ,  1989). We have also previously shown that, in 
these diseased mice, the vast majority of the infected 
cells belong to the B-cell lineage (Huang eta/ . ,  1991). 
This result strongly suggested that infection of B-cells is 
required for the development of the immune disorders. 
In the present study, we have investigated the in v/vo 
T-cell transformation in mice inoculated with helper-free 
stocks of the MAIDS defective virus. We report the estab- 
lishment of leukemic T-cell lines from these MAIDS mice. 
We also report that expansion and malignant transforma- 
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tion of infected T-cell clones are a rare event in this 
system and seem to occur especially when endogenous 
replication-competent MuLVs, rescuing the MAIDS de- 
fective virus, are present in the inoculated mice. 
MATERIALS AND METHODS 
Animals and viruses 
Inbred C57BL/6 and RF/J mice were purchased, re- 
spectively, from Charles River Inc. (St-Constant, Quebec, 
Canada) and from the Jackson Laboratory (Bar Harbor, 
ME). Young (30-40 days old) mice were inoculated as 
before (Huang et aL, 1989, 1992), with helper-free stocks 
of the MAIDS defective virus, the wild-type Du5H (Huang 
et aL, 1989), the chimeric Du5H/Mo-LTR (Huang et aL, 
1991), harboring LTR sequences from Moloney MuLV, 
or the tagged Du5H/neo (Huang et al., 1991) and the 
replication-competent stocks of Du5H/Mo-LTR derived 
from the established T-cell line E20/34 (see below). Mice 
were killed between 12 and 32 weeks postinoculation 
(p.i.), when typical signs of advanced disease were de- 
tected, such as cervical iymphadenopathy (057BL/6 
mice) or neurological signs (RF/J). 
Transplantation and cell cultivation in vitro 
A total of 18 C57BL/6- and 13 RF/J-diseased MAIDS 
mice, which were inoculated at least 3 months previously 
with the helper-free stocks of the tagged DuSH/neo or 
the chimeric DuSH/Mo-LTR MAIDS defective virus, were 
used for transplantation. From each diseased mouse, 
enlarged lymph nodes and spleen (--1 g) were sampled, 
and a 2-ml cel] suspension was prepared in RPMI-1640. 
The inoculum was immediately divided and injected in- 
traperitoneally into two syngeneic recipient healthy 
young (<2 months old) mice, using a 23-gauge needle. 
The recipient mice were routinely monitored for up to 6 
months. An autopsy was performed and enlarged 
lymphoid tissues were again collected, prepared, and 
reinoculated into other syngeneic recipient mice. During 
these steps, cell lines were established in vitro from 
diseased recipients after the first passage (T-l). Briefly, 
lymphoid cells were obtained from an enlarged spleen 
and were dispersed into RPMI-1640/10% FCS, 5 x 10 -~ 
M /~-mercaptoethanol, and antibiotics. The cells were 
seeded at a concentration of 10 e cells/ml into five petri 
dishes (30 × 60 mm) for each cell line. Growing cells 
were split 1=2 twice a week. Lines became established 
after 3 to 4 weeks. Established lines were passaged for 
numerous months• 
Cell surface labeling and cell sorting 
Cells from established cell lines were labeled with 
antibodies. A description of the antibodies has been 
given elsewhere (Paquette et al., 1992). Directly coupled 
cell surface markers monoclonal antibodies fluorescein 
isothiocyanate (FITC)-conjugated 30H12 (murine anti-Thy 
1.2), FITO-145-2011 (murine anti-OD3), FITC-GK 1.5 (mu- 
rine anti-CD4), and FITC-ly2 (murine anti-CD8) were ob- 
tained from Dr. P. R. Sekaly (Clinical Research Institute, 
Montreal, Quebec). The FITC-MRC OX-7 (murine anti-Thy 
1.1) and the FITC-murine anti-# were obtained, respec- 
tively, from Cedariane Laboratories (Hornby, Ontario, 
Canada), and Kirkeengaard & Perry Laboratory, Inc. 
(MD). Cell surface markers HB58 (187-1)(murine anti-C~) 
were obtained from the American Type Culture Collection 
(MD). The Ra36B2 (murine anti-B220) monoclonal anti- 
body was a kind gift of R. Coffman, DNAX Research Insti- 
tute of Cellular and Molecular Biology (Palo Alto, CA). 
The Anti-Mac-1 antibody was from Boehringer-Manneh- 
elm Inc. (Montr6al, Quebec). The anti-Rat IgG-FITC 
(mouse adsorbed, Kirkeengaard & Perry, Inc.) was used 
as a second antibody (for OK, B220, and Mac-l). Cell 
lines were analyzed by fluorescence-activated cell sort- 
ing (FACS) with a FAOScan (Becton-Dickinson). 
Probes 
The D30 (Aziz et aL, 1989), Moloney MuLV U3 LTR 
(Savard et aL, 1987; Poirier and Jolicoeur, 1989), neo 
(Huang et aL, 1991) ecotropic MuLV (Chattopadhyay et 
aL, 1980), (Ig) JH (Poirier and Jolicoeur, 1989; AIt et al., 
1981), OK (Poirier and Jolicoeur, 1989; Lewis et al., 1982; 
Max et aL, 1981), and the/~ T-cell receptor RBL5 (Poirier 
and Jolicoeur, 1989; Caccia et al., 1984) probes have 
been described elsewhere. For Southern blot hybridiza- 
tion, DNA fragments were 32p-labeled as before (Poirier 
and Jolicoeur, 1989; Feinberg and Vogelstein, 1983). 
DNA extraction and hybridization 
. Cellular DNA was prepared, digested with restriction 
endonucleases, and hybridized by the Southern tech- 
nique, essentially as described previously (Huang et al., 
1989; Poirier and Jolicoeur, 1989). 
RNA extraction and hybridization 
Total RNA was extracted (Chomczynski and Sacchi, 
1987) and hybridized with a 32P-labeled D30 probe as 
previously described (Huang et aL, 1992). 
Labeling of cells and immunoprecipitation 
Immunoprecipitation of [3~S]methionine (100 /~Ci/ml)- 
labeled cell extract was carried out with goat anti-p30 
polyclonal antibodies, as described previously (Huang 
and Jolicoeur, 1990)• 
Reverse transcriptase (RT) activity 
The reverse transcriptase activity was performed on 
supernatants of cell lines, as described previously (Hu- 
ang et aL, 1989; Gorska-Flipot eta/., 1992). 
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FIG. 1. Southern blot analysis of TcR gene rearrangements in organs 
of MAIDS mice. DNAs from diseased spleen or lymph nodes of repre- 
sentative mice inoculated with the MAIDS defective Du5H, Du5H/Mo- 
LTR, or Du5Fl/neo viruses, were digested with Hindlll and processed 
by the Southern technique for hybridization with the S2P-labeled cell T 
receptor (TcR-~) RBL5 probe. DNAs are from mice of the C57BL/6 (A) 
or the RF/J (B) strain. As controls, DNAs from the spleen of uninjected 
057BL/6 (A, lane 17) or RF/J (B, lane 16) mice are shown. Note that 
TcR-/~ clonal gene rearrangements were observed for one C57BL/6 (A, 
lane 8) and one RF/J (B, lane 14) mouse. G, germ-line; Numbers, frag- 
ment length in kbp. 
RESULTS 
Rare clonal T-cell expansion in diseased MAIDS mice 
When nonreplicating helper-free stocks of the MAIDS 
defective virus are inoculated into mice, most infected 
cells belong to the B-cell lineage, and T-cells are rarely 
infected bythe defective virus (Huang eta/., 1991; Simard 
et al., 1994). However, after inoculation of replication- 
competent stocks of the uncloned LP-BM5 MAIDS virus, 
T-cell lymphomas have been reported to occur at a rela- 
tively high frequency (Klinken eta/.,  1988; Kubo et al., 
1992; Tang et al., 1992). We investigated the frequency 
at which T-cell lymphomas develop in 36 C57BL/6- and 
35 RF/J-diseased MAIDS mice inoculated with helper- 
free stocks of the molecularly cloned MAIDS defective 
virus (Du5H) and in 16 C57BL/6 mice inoculated with 
replication-competent stocks of the molecularly cloned 
MAIDS defective virus. 
We initially analyzed the clonal rearrangement of the 
T-cell receptor fl gene (TcR fl), in enlarged organs of 
these mice (sacrificed between 12 and 32 weeks p.i.), 
as an indication of clonal growth of T-cell populations. 
Analysis by Southern blots was performed on Hindl l l -  
digested DNAs, using the TcR fl-specific RBL5 probe. 
OIonal TcR/3 gene rearrangements were observed in 1 
of 36 (2.8%) C57BL/6 mice and 1 of 35 (2.8%) RF/J mice 
inoculated with the helper-free stocks of the MAIDS de- 
fective virus (Fig. 1). None of the 16 C57BL/6 mice 
(<6.2%) inoculated with the replication-competent s ocks 
of the MAIDS virus showed a clonal TcR /~ gene re- 
arrangement (data not shown). 
These results indicated that a T-ceil expansion, re- 
flected by a detectable TcR fl gene rearrangement, is 
much less frequent than what has been reported with the 
LP-BM5 virus (Klinken et a/., 1988), when a molecularly 
cloned MAIDS defective virus (pseudotyped with helper 
MuLV or as helper-free stocks) is used for inoculation. 
Malignant T-cell lymphomas derived from diseased 
MAIDS mice 
Since some T-cell clones, possibly malignant, were 
detected in about 2.8% of mice inoculated with our stocks 
of the MAIDS virus, other T-cell clones, too small to be 
detectable by this technique, may also be present in 
these organs. We used a possibly more sensitive tech- 
nique, the in vivo transplantation technique, to detect 
some of the T-cells which may be malignant. 
Lymphoid cells, obtained directly from the enlarged 
spleens and/or lymph nodes of MAIDS mice, were trans- 
planted intraperitoneally into healthy syngeneic recipi- 
ents. These mice were observed routinely for up to 6 
months for the detection of signs of disease. The grafted 
cells from 1 of 18 (5.6%) 057BL/6 MAIDS mice (E2034) 
and 3 of 13 (23.1%) RF/J MAIDS mice (E2028, OS016, 
0S031) were able to induce a proliferative disease in the 
syngeneic recipient mice after a short latency of approxi- 
mately 2 weeks. These transplanted mice showed 
splenomegaly, lymphadenopathy, and liver and kidney 
infiltration. Cells from the enlarged organs of these first 
transplanted recipient mice (T-l) were reimplanted into 
healthy recipients (T-2), which also became diseased 
shortly after the transplantation. The transplantation pro- 
cedure could be maintained for numerous passages in 
vivo (T-3, T-4). All the other C57BL/6 recipient and nonin- 
oculated mice (n -- 10) remained healthy during the ob- 
servation period (6 months). At autopsy, no lesion was 
observed in all these mice. 
On the other hand, all the other transplanted RF/J recip- 
ients (T-1 and T-2), but not the noninoculated RF/J mice 
(n = 10), developed a slow but progressive disease typi- 
cal of MAIDS. The latency indicated that the splenomeg- 
aly and the lymphadenopathy were unlikely caused by 
the growth of lymphoma cells from grafted cells, but were 
rather the result of transmission of the virus produced 
by the transplanted cells. Indeed, using a probe specific 
for ecotropic MuLV (Chattopadhyay et a/., 1980), we ob- 
served that ecotropic MuLV RNAs were expressed in all 
diseased RF/J mice tested (Fig. 2A, lanes 1-8), but not 
in diseased 057BL/6 mice (Fig. 2A, lanes 9-13). Although 
helper-free stocks of the virus were used, the MAIDS 
defective virus was almost always rescued by endoge- 
nous helper MuLVs in the RF/J mice. 
Establishment of malignant T-cell lines from 
transplantable tumors from diseased MAIDS mice 
and their molecular characterization 
To facilitate the characterization of the four distinct 
transplantable tumors obtained in vivo, they were estab- 
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FIG. 2. Northern blot analysis of endogenous ecotropic MuLV in 
organs of MAIDS mice. Total RNAwas extracted from diseased spleens 
or lymph nodes of RF/J (lanes 1 8) or 057BL/6 (lanes 9-13) mice 
inoculated with the helper-free stocks of the Du6H-Mo/LTR defective 
virus. As a positive control, spleen RNA from a 057BL/6 mouse was 
inoculated with the MAIDS defective virus rescued with the replication- 
competent B-tropic G6T2 helper MuLV (lane 14). RNAs were detected 
with the eco probe (A) or with the MAIDS-specific D30 probe (B). 
lished in vitro as cell lines using cells of the recipient T- 
1 mice. To insure that the transplanted tumors and their 
corresponding cell lines were effectively derived from 
the original tumors, we performed a Southern blot analy- 
sis on cellular DNA extracted from them, using the TcR 
/3, C~ and the JH probes to detect gene rearrangements 
specific to T- or B-cells, respectively. A common clonal 
TcR /~ gene rearrangement was effectively observed in 
DNA from tumors (donor and recipients) and cell lines 
E2034 and CS016 (Fig. 3A), indicating that the original T- 
cell expansion seen in the donor mouse was malignant. 
In tumors (donor and recipients) and cell lines E2028 
and CS031, common clonal JH rearrangements were also 
observed (Fig. 3B), but no clonal TcR /3 gene re- 
arrangement was apparent (data not shown). In addition, 
no clonal OK rearrangement was detected in all the trans- 
planted tumors and cell lines (data not shown). These 
data confirmed that the four tumors isolated from the 
recipient mice and the cell lines established from them 
were from an expanded clone detectable in the MAIDS 
donor mice. 
To determine whether MAIDS defective proviruses 
were integrated into these transplantable tumors and 
established cell lines, we tried to visualize newly ac- 
quired virus-cell  junction fragments. DNAs were di- 
gested with EcoRI and analyzed by the Southern blot 
procedure using the virus-specific U3 LTR probe (for tu- 
mors and cell lines E2028 and E2034 derived from mice 
inoculated with Du5H/Mo-LTR) or the nee probe (for tu- 
mors and cell lines CS016 and CS031 derived from mice 
inoculated with Du5H/Neo). In tumors and cell line 
E2034, common proviruses were present in all samples 
analyzed, although noncommon fragments were also de- 
tected (Fig. 4A). In tumors and cell line E2028, a common 
pattern of proviruses was detected between all the sub- 
passages analyzed, but this pattern was not detected in 
the original donor tissue (Fig. 4B). In tumor and cell lines 
0S016 and CS031, newly acquired viral fragment could 
not be detected with the nee probe (data not shown), 
suggesting that either these tumor cells did not harbor 
the MAIDS defective viral genome or that the defective 
viral genome of the inoculated virus was rearranged and 
had lost the nee gene. A result consistent with this later 
hypothesis was that newly acquired common provirus 
could be detected in tumors and cell line CS016 (Fig. 
40), using the D30 probe specific for the MAIDS virus 
(Aziz et al., 1989; Huang et al., 1989), but not in tumors 
and cells line CS031 (data not shown). 
For all four tumors and cell lines, the presence of newly 
acquired proviruses was also assessed by digesting the 
cellular DNAs with Pstl, an enzyme which generates a 
4.2-kbp internal fragment after cleaving within both LTRs 
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FIG. 3. Southern blot analysis of Ig and TcR gene rearrangements 
in transplantable T cell tumors and established T cell lines from MAIDS 
mice. DNAs were extracted from enlarged lymphoid organs (spleen, 
lymph nodes) of MAIDS donor mice and from the T-1 and T-2 transplant- 
able tumors derived from these infiltrated organs. DNAs were digested 
with Hindlll (A) or EcoRI (B) and hybridized with 32P-labeled T cell 
receptor (TcR-~) RBL5 (A) or (Ig) JH (B) probe. G, germ line; Numbers, 
fragment length in kbp. (A) DNAs from the spleen (lanes 1 and 6), 
lymph node (lane 2) of the initial donor E20/34 (lanes 1-5), or CS016 
(lanes 6-10) MAIDS mouse, from the T-1 (lanes 3 and 7), T-2 (lanes 
4, 8, and 9) transplantable T cell tumors, as well as from the established 
cell line (lanes 5 and 10). Lane 11 represents DNA from a normal 
mouse. Arrows represent common TcR clonal gene rearrangement. (B) 
DNAs from the spleen (lanes 1 and 5), lymph node (lane 6) of the initial 
donor E20/28 (lanes 1-4), or CS031 (lanes 5-9) MAIDS mouse, from 
the T-1 (lanes 2 and 7), T-2 (lanes 3 and 8) transplantable T cell tumors, 
as well as from established ceil line (lanes 4 and 9). Lane 10 represents 
DNA from a normal mouse. Arrows represent common JH clonal gene 
rearrangement. 
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FIG. 4. Southern blot analysis of provirus integration in transplantable 
T cell tumors and established T cell lines from MAIDS mice. The same 
DNAs shown in Fig. 3 were digested with EcoRI (A and B), Sac/ (C), 
or Pstl (A' and B') and hybridized with 32p-labeled Moloney U3 LTR (A, 
A', B, B') or D30 (C) probe. (A and A') DNAs from the spleen (lane 1), 
lymph node (lane 2) of the initial donor mouse E20/34, from the T-1 
(lanes 3 and 4), T-2 (lanes 5 and 6) transplantable T cell tumors, as 
weir as from the established cell line E20/34 (lane 7). Lane 8 represents 
DNA from a normal 057BL/6 mouse. (B and B') DNAs from the spleen 
(lane 1) of the initial donor mouse E20/28, from the Tq (lane 2), T-2 
(lane 3) transplantable T cell tumors, as well as from the established 
cell line E20/28 (lane 4). Lane 5 represents DNA from a normal RF/J 
mouse. (C) DNAs from the spleen of the initial donor mouse 0S016 
(lane 1), from the T-1 (lane 2) and T-2 (lanes 3 and 4) transplantable T 
cell tumors, as well as from the established cell line CS016 (lane 5). 
Lane 6 represents DNA from a normal RF/J mouse. Arrows show com- 
mon newly acquired virus-cell junction fragments for each line. 
of the MAIDS defective viral genome (Huang etal. ,  1989). 
Hybridization was done with the Moloney MuLV-specif ic 
U3 LTR probe or the D30 probe. The expected 4.2-kbp 
fragment was detected in tumors and cell line E2034 
DNA (Fig. 4A', lanes 1 to 6), but not in the other tumors. 
In tumors and cell line E2028 DNA, an unexpected full- 
length provirus of around 8 kbp was detected (Fig. 4B', 
lanes 1 to 4). In the other tumors and cell lines CS016 
and CS031, no internal 4.2-kbp Pstl fragment could be 
detected with the D30 probe (data not shown). In these 
two tumors, it was neither possible to detect a full-length 
8-kbp provirus, most probably because of the high back- 
ground obtained on cellular DNA with this probe in this 
size range (data not shown). A summary of the data ob- 
tained by Southern blot analysis of these four tumors and 
cell lines is presented in Table 1. It appears that all four 
transplantable tumors and cell lines were derived from 
a clone already detected in the original donor enlarged 
organ. 
The mal ignant T-cells derived from diseased MAIDS 
mice are virus producers 
To further characterize these lines, Northern blot anal- 
ysis was performed with the D30 probe, specific for the 
MAIDS defective virus (Aziz et al., 1989; Huang et al., 
1989). The expected 4.2-kb MAIDS defective virus RNA, 
in addition to other RNA species was revealed in E2034 
ceils (data not shown). However, in the other three cell 
lines, which were derived from RF/J mice, no 4.2-kb RNA 
species was detected and an apparently full-length 8-kb 
RNA was observed (Table 2). These RNA species may 
represent aberrant transcripts from the MAIDS defective 
virus since the D30 probe was not detecting endogenous 
MuLV RNAs in most of the RF/J mouse organs in which 
these aberrant transcripts were shown to be present (Fig. 
2, compare A and B). Moreover, the D30 probe did not 
detect the full-length (8.0 kb) and the env-specific RNAs 
of the B-tropic ecotropic G6T2 helper MuLV used as a 
positive control (Huang etaL ,  1989) (Fig. 2B, lane 14). 
To analyze the viral proteins in these cell lines, we 
used the immunoprecipitation technique with the goat 
anti-p30 antibodies. In E2034 cells, both the Pr60 gag, en- 
coded by the MAIDS defective virus (Huang and Joli- 
coeur, 1990), and the Pr65 gag encoded by helper MuLV, 
were clearly detected (Fig, 5, lane 1), indicating that the 
MAIDS defective virus inoculated as a helper-free stock 
was rescued by endogenous helper MuLV in this mouse 
cell line. In the E2028 RF/J cell line, a Pr60gag-related 
species, possibly slightly longer, was detected (Fig. 5, 
lane 2), but no evidence of the Pr60 gag was found in lines 
TABLE 1 
CHARACTERISTICS OF THE TRANSPLANTABLE TUMORS AND ESTABLISHED CELL LINES DERIVED FROM DISEASED C57BL/6 OR RF/J MICE INJECTED 
WITH HELPER-FREE STOCKS OETHE MAIDS DEFECTIVE VIRUS 
Latency of disease Rearrangement c 
Tumors and Mouse Defective induction (days) b Clonal provirus 
cell lines strain virus a (tumors) TcR JH C, integration 
Provirus 
length 
E20/34 C57BW67 U3M 13 + - - + 
E20/28 R F/J U3 M 10 + - +~ 
0S016 RF/J NED 14 + - - + 
0S031 RF/J NED 13 - + - N.D. ~ 
4.2 
8 
N.D. 
N.D. 
a Helper-free chimeric DuSH/Mo-LTR (U3M) or tagged Du5H/Neo defective MAIDS viruses were inoculated. 
Time (in days) at which recipient T-1 mice were moribound after receiving 0.5 g of enlarged lymphoid tissues. 
c Rearrangement found in transplantable tumors. 
Net found in donor DNA, but detected in transplanted tumors and cell lines. 
e N.D., not detected. 
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TABLE 2 
CHARACTERISTICS OF THE CELL LINES ESTABLISHED /n Vitro FROM TRANSPLANTABLE TUMORS 
OF 057BL/6 OR RF/J MICE INOCULATED WITH THE MAIDS VIRUS 
CIonality between RNA 
Cell line a Mouse strain tumor and cell line s detected (kb) sRT c 
Viral protein 
detected ~ 
E20/34 C57BL/6 + 4.2, --3.5, --8 + + + 
E20/28 RF/J + --8 + 
0S0t6 RF/J + ~8 + 
0S031 RF/J + -8  + 
Pr60, Pr65 
~Pr60, Pr65 
Pr65 
Pr65 
a All lines were derived from tumors after their first transplantation (T1). 
Clonality was measured by TcR, JH, or OK rearrangements or by provirus integration. 
° RT, reverse transcriptase assay performed on medium of cells in culture. 
~The precursor Pr65 ~ag is encoded by helper MuLV while the Pr60 g~g is encoded by the defective genome of the MAIDS virus. 
CS016 and CS031 (Fig. 5, lanes 3 and 4). However, the 
Pr65 gag was detected in all three RF/J cell l ines (Fig. 
5, lanes 2-4).  Addit ional species of distinct molecular 
weight, possibly representing aberrant proteins, could 
also be detected (Fig. 5). 
We also quantif ied virus production of these cells by 
evaluating the RT activity in their supernatant. The RT 
activity was strongly positive for the C57BL/6 cell line 
E2034 (>600,000 cpm) and weakly positive for the RF/J 
cell l ines (20,000-50,000 cpm) (Table 2). 
A summary on the characteristics of the cell l ines is 
given in Table 2. Together, these data indicate the pres- 
ence of repl ication-competent MuLV in all of these four 
cell lines, although helper-free stocks of the MAIDS de- 
fective virus was inoculated. 
Cell surface phenotype of the mal ignant T-cell  l ines 
derived from diseased MAIDS mice 
To better identify these malignant cells, they were 
characterized in more details by fluorocytometry, using 
a FACScan, and markers specif ic for T-cells (Thy-1, CD3, 
CD4, CD8), for B-cells (K, if, B220), and for macrophages 
(Mac-l) .  These data are shown in Fig. 6. The three cell 
l ines established from the RF/J tumors were phenotypi- 
cally immature T-cells (Thy-1 +, CD3-, CD4 +, CD8+). Inter- 
estingly, one additional cell line established from tumor 
CS016 after the fifth transplantation (T-5) was Thy 1.2 +, 
CD4 +, CD8 +, and CD3 + (data not shown), indicating the 
differentiation of this tumor in vivo from CD3-  to CD3 +. 
These three T cell l ines were also Mac-1 +. Transcription 
of Mac-1 RNA was confirmed by Northern blot analysis, 
using Mac- l -speci f ic  probe, for cell- l ine CS016 (data not 
shown). The C57BL/6 T-cell line E2034 exhibited the phe- 
notype of mature T-cell (Thy-1 +, CD3 +, CD4 ÷, CD8-). 
Altogether, these results showed that malignant T- 
cells, which can be established in vitro as cell lines, are 
present as rare clones in animals inoculated with helper- 
free stocks of the MAIDS defective virus. 
DISCUSSION 
In our groups of mice inoculated with helper-free 
stocks of the MAIDS defective virus, we found that T- 
cell lymphoma (detected by TcR/~ gene rearrangement 
in enlarged lymphoid organs or by transplantation) was 
a relatively rare (--6%) phenomenon in 057BL/6 mice 
and may be more common (23%) in RF/J mice. These 
results contrast with previous observations in which rep- 
l ication-competent stocks LP-BM5 strain of the MAIDS 
defective virus were used. Klinken et al. (1988) reported 
clonal TcRp rearrangements (very likely reflecting malig- 
nant T-cell expansion) in 35% of their MAIDS mice inocu- 
lated with the LP-BM5 MAIDS virus stocks. Kubo et al. 
(1992) also obtained transplantable T-cell lymphomas 
from C57BL/6 donor MAIDS mice at high frequency (71%), 
using (057BL/6 x BALB/c) F1 nude recipient mice. Simi- 
larly, Tang etaL (1992)derived T-cell lymphomas in recip- 
ient SOlD mice inoculated with cells from 057BL/6 
MAIDS donor mice at a frequency of 25% (at 9 weeks 
1 2 3 4 5 6 
Pr65 - 
P r60  r" 
FIG. 5. lmmunoprecipitation ofthe precursor gag proteins in cell lines 
established from MAIDS mice. Cells were from the established lines 
E20/34 (lane 1), E20/28 (lane 2), 0S016 (lane 3), and CS031 (lane 4), 
from control noninfected NIH/3T3 (lane 5) or control infected t#2 cells 
transfected with the MAIDS defective virus (lane 6). Cells were labeled 
with [35S]methionine as described under Materials and Methods and 
the labeled proteins were immunoprecipitated with goat anti-gag p30 
anti-serum. Immunoprecipitated proteins were separated by 5 to 20% 
SDS-PAGE. Note the Pr65 g~g and Pr60 ~g encoded by helper MuLV 
and by the defective MAIDS virus, respectively. 
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FiG. 6. Cell surface phenotype of established celt lines from MAIDS mice. Cells from the established line E20/28, CS016, CS031, E20/34, and 
from control 057BL/6 spleen or peritoneal adherent macrophages (~) were stained with a panel of monoclonal antibodies specific for T cells (Thy 
1.1 or 1.2, CD3, OD4, and CDS), B cells (B220, C~, #), or macrophages (Mac-l). Cell surface stainings were carried out by using either a direct 
(Thy-1, CD3, CD4, CD8, if) or an indirect (19200, C~, Mac-l) immunofluorescence assay. Stained cells were analyzed on a FACScan. At least 5000 
cells are Jncluded in each fluorescence histogram. The vertical lines indicate the lower limits of the positivity, based on negative controls (cells 
unstained (direct labeling) or stained with only the FITC Rat anti-mouse IgG (indirect labeling)). Note that the RF/J cell lines (E20/28, CS016, CS031) 
are Thyl -', CD3-, CD4 +, CD8 +, Mac-1 +, while the C57BL/6 cell line (E20/34) is Thy-1 +, CD3 +, CD4 +, CD8-, Mac-l-.  
p.i.), 40% (at 12 weeks p.i.), and 83% (at 31 or 32 weeks 
pJ.). The discrepancies between those studies and this 
one could be related to the age at which these mice 
were killed, to the environment in which they were main- 
tained, to the recipient mice used, and more likely to the 
virus stocks inoculated. The crude LP-BM5 virus stocks 
used by these investigators (Klinken et aL, 1988; Kubo 
et al., 1992; Tang et aL, 1992) contain a mixture of differ- 
ent helper MuLVs (ecotropic and mink-cell-focus-forming 
viruses) (Haas and Reshef, 1980; Hartley et al., 1989; 
Chattopadhyay et aL, 1989, 1991). These helper MuLVs 
alone or pseudotyped with the MAIDS defective virus 
may contribute to the T-cell expansion observed by these 
investigators. In contrast, our stocks of the MAIDS defec- 
tive virus were helper-free, thus significantly reducing 
virus reinfection and the contribution of the helper MuLV 
in T-cell transformation. 
The apparent higher frequency of T-cell lymphomas 
detected in RF/J mice, as compared to C57BL/6 mice, 
with the same virus preparations, may not be significant 
because of the low number of tumors observed. If real, 
this difference is likely to reflect the genetic background 
of RF/J mice. These are known to develop a relatively 
high incidence of spontaneous thymic lymphomas 
(Gross, 1970; Goodenow and Lilly, 1984) and to be very 
susceptible to T-cell tumor development after irradiation 
or chemical treatment {Gross, 1970; Duran-Reynals et al., 
1978). Klinken et al. (1988) also detected a difference 
in the TcR/g clonal rearrangements in MAIDS lymphoid 
organs from two different strains of mice. In addition, the 
apparent different incidence of T cell lymphoma arising 
in C57BL/6 and RF/J MAIDS mice may reflect the pres- 
ence of replicating endogenous MuLV in RF/J mice. We 
have indeed detected endogenous ecotropic MuLVs in 
all RF/J mice, but only rarely in C57BL/6 mice, inoculated 
with the helper-free stocks of the MAIDS defective virus 
(Fig. 2A). These MuLVs are likely to serve as helpers to 
rescue the MAIDS defective virus. In agreement with this 
interpretation, we observed that all recipient RF/J mice, 
but not the 057BL/6 mice, transplanted with grafted cells 
from syngeneic donor-diseased MAIDS mice developed 
the MAIDS syndrome. In addition, helper MuLVs were 
present in the three transplantable T-cell lymphomas and 
cell lines originating from RF/J mice. Unexpectedly, 
helper MuLVs were also detected in the T-ceN lymphoma 
derived from a C57BL/6 mouse. These helper MuLVs are 
likely to be derived from endogenous MuLV sequences. 
Together, these results suggest that T-cell lymphoma 
develop in MAIDS mice only when helper MuLVs are 
present to allow reinfection of T-cells. These endogenous 
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helper MuLVs may contribute to T-cell transformation, 
although our data do not allow us to establish this causal 
role. However, not all helper MuLV may be of equal effi- 
ciency in contributing to T-cell transformation in MAIDS 
mice as none of the .16 mice inoculated with the helper- 
competent stocks of the MAIDS defective virus produced 
by the E20/34 T-cell line develop T-cell lymphoma, but 
all develop MAIDS. 
In addition, the MAIDS defective viral genome itself 
may contribute to T-cell transformation in vivo. Indeed, 
the defective viral genome and its gene product Pr60 gag 
was clearly detected in the cell line E20/34. Also, all the 
T-cell tumors derived by Kubo et al. (1992) and Tang et 
al. (1992) harbor the MAIDS defective genome. However, 
the specific MAIDS Pr60 gag protein was not detected in 
two of four transformed RF/J T-cell lines, suggesting that 
the presence of this specific MAIDS viral protein may 
not be essential for the transformation of T-cells. More 
specific experiments will have to be designed to deter- 
mine whether the defective virus is involved in T-cell 
transformation. 
The four T-cell lines that we have established were 
phenotypically distinct depending on their origin. The tu- 
mor cells originating from the C57BL/6 mouse were ma- 
ture CD4 + CD8- T-cells, a phenotype similar to the tu- 
mors obtained byTang eta/. (1992), while those originat- 
ing from RF/J mice were immature CD4+CD8 + T-cells. 
These RF/J cell lines were CD3- and only one had a 
rearranged TcR/3 gene, indicating they were derived from 
early T-cell progenitors. All these three lines also ex- 
pressed Mac-l, a macrophage/monocyte cell surface 
marker. This constitutes a particularly intriguing pheno- 
type. A subpopulation of immature Mac-1 + precursor T- 
cells is known to be present among murine bone marrow 
cells (Holmes et aL, 1988). The virus may have initially 
infected this population. Alternatively, the expression of 
the Mac-1 molecule may have been induced in these 
immature transformed T-cells after their infection. Our 
present data do not allow us to discriminate between 
both possibilities. All of our four cell lines were Thy-l+. 
This finding contrasts with the Thy-1 phenotype of the 
T-cell lymphomas derived by Kubo et aL (1992) from 
C57BL/6 MAIDS mice, after transplantation of their 
lymphoid tissues into nude mice. The different trans- 
plantation protocols or virus stocks used by both groups 
may explain the preferential growth of one type of T-cell 
lymphoma. 
Interestingly, the transplantation protocol used here 
did not allow the growth of the infected B cells which 
constitute the majority of the infected cells in animals 
inoculated with helper-free stocks of the MAIDS defec- 
tive virus (Huang et aL, 1991). Alternative experimental 
protocols will be needed to establish these cells in vitro 
early after their expansion in vivo. 
In summary, our study shows that transformation of T- 
cells in two strains of mice inoculated with the MAIDS 
defective virus is a rare event whose frequency appears 
to depend on the presence of pathogenic helper virus in 
the viral stocks used or in mouse strains inoculated. T- 
cell lines can be established relatively easily out of these 
T-cell tumors, suggesting that these T-cell tumors are 
fairly aggressive. The availability of these T-cell lines 
would be useful to determine whether they have con- 
served some of the characteristics of the anergic T-cells 
in vivo. 
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